CINECA IRIS Institutional Research Information System

ROLLA, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.428
EU - Europa 2.114
AS - Asia 737
AF - Africa 63
SA - Sud America 23
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 6.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.381
CN - Cina 438
IT - Italia 423
DE - Germania 313
SE - Svezia 311
IE - Irlanda 261
FR - Francia 146
UA - Ucraina 143
FI - Finlandia 109
VN - Vietnam 86
GB - Regno Unito 80
KR - Corea 68
PL - Polonia 62
AT - Austria 60
DK - Danimarca 57
SN - Senegal 53
BE - Belgio 45
CA - Canada 42
IN - India 39
GR - Grecia 25
ES - Italia 22
JP - Giappone 22
NL - Olanda 18
TR - Turchia 15
TW - Taiwan 15
AU - Australia 12
EU - Europa 12
IL - Israele 11
SG - Singapore 11
IR - Iran 10
BR - Brasile 9
RU - Federazione Russa 7
CO - Colombia 6
HK - Hong Kong 6
RO - Romania 6
MU - Mauritius 5
MX - Messico 5
NO - Norvegia 5
CZ - Repubblica Ceca 4
NZ - Nuova Zelanda 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
CH - Svizzera 3
LB - Libano 3
MK - Macedonia 3
UY - Uruguay 3
AR - Argentina 2
BG - Bulgaria 2
EC - Ecuador 2
EE - Estonia 2
HU - Ungheria 2
ID - Indonesia 2
PK - Pakistan 2
RS - Serbia 2
A1 - Anonimo 1
CL - Cile 1
DZ - Algeria 1
HR - Croazia 1
JO - Giordania 1
MD - Moldavia 1
NP - Nepal 1
PT - Portogallo 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 6.394
Salva come PNG Salva come JPEG
Città #
Chandler 607
Beijing 265
Ann Arbor 263
Dublin 257
Fairfield 177
Houston 174
Fremont 159
Torino 127
Ashburn 122
Wilmington 108
Dearborn 106
Nyköping 100
Woodbridge 94
Jacksonville 89
Medford 88
Villeurbanne 82
Princeton 80
Dong Ket 72
Cambridge 64
Seattle 63
Vienna 60
Warsaw 58
Turin 52
Redwood City 51
Brussels 39
Pisa 38
Boardman 32
Washington 28
Milan 26
Boston 22
San Diego 22
Guangzhou 21
Toronto 20
Falls Church 15
Nanjing 15
San Mateo 14
Taipei 14
Shanghai 12
Hangzhou 11
Hefei 11
Mountain View 11
Norwalk 11
Kunming 9
Nürnberg 9
Wuhan 9
Chengdu 8
Ottawa 8
Tokyo 8
Amsterdam 7
Dallas 7
Duncan 7
Düsseldorf 7
Menlo Park 7
Rome 7
Coventry 6
Hanover 6
Hebei 6
Istanbul 6
Jinan 6
Munich 6
Phoenix 6
Alessandria 5
Des Moines 5
Helsinki 5
Kharkiv 5
Kozani 5
Madrid 5
New York 5
Stavanger 5
Bergamo 4
Central District 4
Heidelberg 4
Leawood 4
Montreal 4
Montréal 4
Netanya 4
Oldenburg 4
Paris 4
Seoul 4
Sevilla 4
Silver Spring 4
Stockholm 4
Upper Marlboro 4
Aci Catena 3
Canzo 3
Chicago 3
Cork 3
Curitiba 3
Gazi 3
Jerusalem 3
Johannesburg 3
Lanzhou 3
Montevideo 3
Nanchang 3
Palermo 3
Pamplona 3
Patna 3
Shenyang 3
Skopje 3
Verona 3
Totale 3.962
Salva come PNG Salva come JPEG
Nome #
Vaccination with ENO1 DNA Prolongs Survival of Genetically Engineered Mice with Pancreatic Cancer. 378
Pregnancy epigenetic signature in T helper 17 and T regulatory cells in multiple sclerosis 371
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis 261
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 199
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months 178
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months 164
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 164
D-dimer Increasing After First Alemtuzumab Administration in a Multiple Sclerosis Patient 148
In Human Multiple sclerosis, T helper 17 lymphocytes display increased levels of JAK2 that stabilize cell surface IFN-YR2chain 144
T helper subsets changes in alemtuzumab multiple sclerosis treated patients: the recovery of immune system capacity as a possible indicator to treatment 141
Alterations in gut microbiome are associated with the onset of multiple sclerosis: an Italian pivotal study 134
Lack of CD4 + T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses 132
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 130
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View 127
Natalizumab in Multiple Sclerosis: Long-Term Management 124
CHARACTERIZATION OF AUTOREACTIVE TCR REPERTOIRE IN PATIENTS AFFECTED BYMULTIPLE SCLEROSIS. 123
How do Treg cell function and related cytokines levels change in alemtuzumab treated patients? A 24 months immunological study 111
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. 97
THE ACUTE-PHASE PROTEIN HEMOPEXIN IS A NEGATIVE REGULATOR OF TH17 RESPONSE AND EXPERIMENTAL AUTOIMMUNE ENCEPHALOMIELITIS DEVELOPMENT 93
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice 92
Computational modeling of the immune response in multiple sclerosis using epimod framework 91
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions 90
THE BLOCKADE OF PLASMINOGEN-ALPHA-ENOLASE INTERACTION INHIBITS THE INVASION OF PANCREATIC CANCER CELLS. 85
Treg Cell Function and Related Cytokines and Chemokines Changes during Alemtuzumab Treatment: a 24 Months Immunological Study 85
Erbb2 DNA vaccine combined with Treg cell deletion enhances antibody response and reveals latent low-avidity T cells. Potential and limits of its therapeutic efficacy. 84
T-Helper (Th)22, a Newly Identified Lymphocyte Subset, Increases 1-3 Months before an MS Relapse and It Is Not Sensitive to IFN beta 83
Circulating T helper 22 cells increase in multiple sclerosis patients:phenotypical and functional characterization. 82
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice 81
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials 80
Estrogen receptor alpha in peripheral blood lymphocytes of multiple sclerosis patients: a pivotal study of its role in pregnant patients 79
Gut microbiota alteration in Clinically Isolated Syndrome: a pilot study 77
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. 76
T HELPER 22 CELLS INCREASE IN MULTIPLE SCELROSIS PATIENTS: PHENOTYPICAL AND FUNCTIONAL CHARACTERIZATION 75
T HELPER 22 CELLS INCREASE IN MULTIPLE SCLEROSIS PATIENTS: PHENOTYPICAL AND FUNCTIONAL CHARACTERIZATION 74
T Regulatories (Tregs) and suppressor cytokine mRNA (IL-10, TGF-beta, IL-27) increase after Alemtuzumab in MS: First 25 Month Immunological Report on 323 and 324 Genzyme trials 74
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation 74
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity 73
Long Term immunological alemtuzumab effect: increase in Tregsuppressor function 72
Estrogen receptor alpha regulates key genomic regions of t-helper 17 and T-regulatory cells in Multiple Sclerosis: a new potential biomarker of disease activity. 71
Epigenetic mechanisms regulate T helper 17 and T regulatory cells during pregnancy in multiple sclerosis. 71
Th17, an effector T Lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon beta 70
Estrogen Receptor Alpha Regulates Key Genomic Regions of Thelper 17 and T Regulatory Cells in Multiple Sclerosis: A New Potential Biomarker of Disease Activity 70
T-helper 17 lymphocytes during MS relapses: antigen specificity and cytokine production. A multicentre longitunal study 68
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 68
Estrogen receptor-alpha regulates epigenetic changes on genomic regulatory regions: potential biomarkers in multiple sclerosis outcomes 68
Epigenetic signature in T helper 17 and regulatory T cells in multiple sclerosis patients during pregnancy 68
can the increase of T-helper 17 Lymphocyte percentage in peripheral blood anticipate a relapse in relapsing remitting multiple sclerosis? 67
T-helper (Th) 22, a newly identified lymphocyte subset, increases 1-3 months before an MS relapse and it is not sensitive to INF beta 64
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis 64
Chromatin remodeling in Th17 and Treg plasticity induced by E2 immunomodulation 64
Th17 lymphocytes are expandend in multiple sclerosis and are inhibited by interferon beta 63
Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice 61
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-  61
How to treat patients after natalizumab discontinuation: the TY-STOP 2 study, an Italian, prospective and multicenter study 59
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 58
T helper 22 increase in multiple sclerosis patints: phenotypical and functional characterization 55
JAK2 is overexpressed in human multiple sclerosis Th17 cells andstabilizes cell surface expression of IFN-gammaR2. 53
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up 53
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario 50
Does Th17 response be harnessed by the antigen DNAvaccination against pancreatic adenocarcinomas? 43
Immune Trait Shifts in Association With Tobacco Smoking: A Study in Healthy Women 43
Phenotypical and functional characterization of T Helper 22 cells inMultiple Sclerosis patients 42
Gut microbiota and metagenomic diversity in Clinical Isolated Syndrome 42
Longitudinal analysis of IL-17 and/or IL-22 producing CD4+ T lymphocytes in relapsing remitting multiple sclerosis 40
Six year prospective immunological study of alemtuzumab treated patients: identification of markers of the clinical response 40
T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy 39
Mycobacterium tuberculosis in the adjuvant modulates the balance of Th immune response to self-antigen of the CNS without influencing a "core" repertoire of specific T cells 39
Role of Th22 expansion in multiple sclerosis disease activity 39
Multiparametric analysis of Th17 and Th22 cells discloses their pathogenicity in human multiple sclerosis 37
Host genetics and gut microbiome: Perspectives for multiple sclerosis 36
Protective Immunity Against neu+ Carcinomas Elicited By Electroporation Of Plasmids Coding For Decreasing Fragments Of rat neu Extracellular Domain 33
JAK2 is overexpressed in human multiple sclerosis Th17 cells and stabilizes cell surface expression of IFN-gammaR2 30
Past and future of the molecular characterization of the T cell repertoire: Some highlights of eli sercarz’s contributions 18
Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies 16
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 10
A new computational workflow to guide personalized drug therapy 9
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 8
ALTERATIONS IN GUT MICROBIOME COMPOSITION ARE ASSOCIATED WITH THE ONSET AND COURSE OF MULTIPLE SCLEROSIS: AN ITALIAN COHORT STUDY 3
Feeding the gut microbiome: impact on multiple sclerosis 3
Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis 2
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 2
Totale 6.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.361
article - articoli 0
book - libri 0
conference - conferenze 7.337
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019341 0 0 0 0 0 32 7 73 17 59 91 62
2019/2020900 28 27 41 106 56 178 96 71 75 99 58 65
2020/2021967 73 69 42 110 104 79 71 43 98 63 79 136
2021/20221.110 36 31 40 72 63 72 78 80 48 152 232 206
2022/20231.591 147 136 48 186 141 353 127 107 187 46 73 40
2023/2024415 107 111 59 36 56 46 0 0 0 0 0 0
Totale 6.646